Cumplimiento en España de la norma de prescribir cuatro fármacos en la fase intensiva del tratamiento estándar de la tuberculosis

Translated title of the contribution: Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment

José María García-García, Teresa Rodrigo, Martí Casals, Juan Ruiz-Manzano, Teresa Pascual-Pascual, Joan A. Caylà, R. Agüero, J. L. Alcázar, N. Altet, L. Altube, F. Álvarez Navascués, L. Anibarro, M. Barrón, P. Bermúdez, R. Blanquer, L. Borderías, A. Bustamante, J. L. Calpe, J. A. Caminero, F. Cañas & 62 others F. Casas, X. Casas, E. Cases, R. Castrodeza, J. J. Cebrián, J. E. Ciruelos, A. E. Delgado, M. L. de Souza, D. Díaz, B. Fernández, A. Fernández, J. Gallardo, M. Gallego, M. M. GarcíaClemente, C. García, F. J. García, F. J. Garros, J. A. Gullón, C. Hidalgo, M. Iglesias, G. Jiménez, M. A. Jiménez, J. M. Kindelan, J. Laparra, R. Lera, T. Lloret, M. Marín, J. T. Martínez, E. Martínez, A. Martínez, J. F. Medina, C. Melero, C. Milà, I. Mir, C. Morales, M. A. Morales, V. Moreno, A. Muñoz, L. Muñoz, C. Muñoz, J. A. Muñoz, I. Parra, A. Penas, J. A. Pérez, P. Rivas, J. Rodríguez, J. Ruiz-Manzano, J. Sala, M. Sánchez, P. Sánchez, F. Sanz, M. Somoza, E. Trujillo, E. Valencia, A. Vargas, I. Vidal, R. Vidal, M. A. Villanueva, A. Villar, M. Vizcaya, M. Zabaleta, G. Zubillaga

Research output: Contribution to journalArticle

Abstract

Introduction: International and Spanish guidelines recommend a 4-drug regimen in the intensive treatment of tuberculosis (TB). The aim of our study was to determine if these recommendations are followed in Spain, and the factors associated with the use of 3 drugs (standard regimen without ethambutol). Methodology: Observational, multicenter, retrospective analysis of data from patients diagnosed with TB in practically all Spanish Autonomous Communities between 2007 and 2102. Factors associated with the use of 3 drugs were analyzed using logistic regression, and odds ratios (OR) and corresponding 95% confidence intervals (CI) were calculated. Results: A total of 3,189 patients were included, 1,413 (44.3%) of whom received 3 drugs. The percentage of 3-drug users among patients with positive sputum smear was 41.2%; among patients with resistance to at least 1 drug, 36.1%; among HIV-infected patients, 31.4%; and among immigrants, 24.8%. Factors associated with the use of 3 drugs were: female sex (OR = 1.18; CI: 1.00-1.39); native Spanish (OR = 3.09; CI: 2.58-3.70); retired (OR = 1.42; CI: 1.14-1.77); homeless (OR = 3.10; CI: 1.52-6.43); living alone (OR = 1.62; CI: 1.11-2.36); living in a family (OR = 1.97; CI: 1.48-2.65); seen by specialists in the region (OR = 1.37; CI: 1.10;1.70); no HIV infection (OR = 1.63; CI: 1.09-2.48); and negative sputum smear with positive culture (OR = 1.59; CI: 1.25-2.02). Conclusions: A large proportion of TB patients receive intensive treatment with 3 drugs. TB treatment recommendations should be followed, both in routine clinical practice and by the National Plan for Prevention and Control of Tuberculosis in Spain.

Original languageSpanish
Pages (from-to)262-268
Number of pages7
JournalArchivos de Bronconeumologia
Volume52
Issue number5
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Drug Prescriptions
Compliance
Tuberculosis
Odds Ratio
Guidelines
Confidence Intervals
Pharmaceutical Preparations
Therapeutics
Sputum
Spain
Ethambutol
Sex Ratio
Drug Users
HIV Infections
Logistic Models
HIV

Keywords

  • Adherence
  • Guidelines
  • Treatment
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

García-García, J. M., Rodrigo, T., Casals, M., Ruiz-Manzano, J., Pascual-Pascual, T., Caylà, J. A., ... Zubillaga, G. (2016). Cumplimiento en España de la norma de prescribir cuatro fármacos en la fase intensiva del tratamiento estándar de la tuberculosis. Archivos de Bronconeumologia, 52(5), 262-268. https://doi.org/10.1016/j.arbres.2015.11.007

Cumplimiento en España de la norma de prescribir cuatro fármacos en la fase intensiva del tratamiento estándar de la tuberculosis. / García-García, José María; Rodrigo, Teresa; Casals, Martí; Ruiz-Manzano, Juan; Pascual-Pascual, Teresa; Caylà, Joan A.; Agüero, R.; Alcázar, J. L.; Altet, N.; Altube, L.; Álvarez Navascués, F.; Anibarro, L.; Barrón, M.; Bermúdez, P.; Blanquer, R.; Borderías, L.; Bustamante, A.; Calpe, J. L.; Caminero, J. A.; Cañas, F.; Casas, F.; Casas, X.; Cases, E.; Castrodeza, R.; Cebrián, J. J.; Ciruelos, J. E.; Delgado, A. E.; de Souza, M. L.; Díaz, D.; Fernández, B.; Fernández, A.; Gallardo, J.; Gallego, M.; GarcíaClemente, M. M.; García, C.; García, F. J.; Garros, F. J.; Gullón, J. A.; Hidalgo, C.; Iglesias, M.; Jiménez, G.; Jiménez, M. A.; Kindelan, J. M.; Laparra, J.; Lera, R.; Lloret, T.; Marín, M.; Martínez, J. T.; Martínez, E.; Martínez, A.; Medina, J. F.; Melero, C.; Milà, C.; Mir, I.; Morales, C.; Morales, M. A.; Moreno, V.; Muñoz, A.; Muñoz, L.; Muñoz, C.; Muñoz, J. A.; Parra, I.; Penas, A.; Pérez, J. A.; Rivas, P.; Rodríguez, J.; Ruiz-Manzano, J.; Sala, J.; Sánchez, M.; Sánchez, P.; Sanz, F.; Somoza, M.; Trujillo, E.; Valencia, E.; Vargas, A.; Vidal, I.; Vidal, R.; Villanueva, M. A.; Villar, A.; Vizcaya, M.; Zabaleta, M.; Zubillaga, G.

In: Archivos de Bronconeumologia, Vol. 52, No. 5, 01.05.2016, p. 262-268.

Research output: Contribution to journalArticle

García-García, JM, Rodrigo, T, Casals, M, Ruiz-Manzano, J, Pascual-Pascual, T, Caylà, JA, Agüero, R, Alcázar, JL, Altet, N, Altube, L, Álvarez Navascués, F, Anibarro, L, Barrón, M, Bermúdez, P, Blanquer, R, Borderías, L, Bustamante, A, Calpe, JL, Caminero, JA, Cañas, F, Casas, F, Casas, X, Cases, E, Castrodeza, R, Cebrián, JJ, Ciruelos, JE, Delgado, AE, de Souza, ML, Díaz, D, Fernández, B, Fernández, A, Gallardo, J, Gallego, M, GarcíaClemente, MM, García, C, García, FJ, Garros, FJ, Gullón, JA, Hidalgo, C, Iglesias, M, Jiménez, G, Jiménez, MA, Kindelan, JM, Laparra, J, Lera, R, Lloret, T, Marín, M, Martínez, JT, Martínez, E, Martínez, A, Medina, JF, Melero, C, Milà, C, Mir, I, Morales, C, Morales, MA, Moreno, V, Muñoz, A, Muñoz, L, Muñoz, C, Muñoz, JA, Parra, I, Penas, A, Pérez, JA, Rivas, P, Rodríguez, J, Ruiz-Manzano, J, Sala, J, Sánchez, M, Sánchez, P, Sanz, F, Somoza, M, Trujillo, E, Valencia, E, Vargas, A, Vidal, I, Vidal, R, Villanueva, MA, Villar, A, Vizcaya, M, Zabaleta, M & Zubillaga, G 2016, 'Cumplimiento en España de la norma de prescribir cuatro fármacos en la fase intensiva del tratamiento estándar de la tuberculosis', Archivos de Bronconeumologia, vol. 52, no. 5, pp. 262-268. https://doi.org/10.1016/j.arbres.2015.11.007
García-García, José María ; Rodrigo, Teresa ; Casals, Martí ; Ruiz-Manzano, Juan ; Pascual-Pascual, Teresa ; Caylà, Joan A. ; Agüero, R. ; Alcázar, J. L. ; Altet, N. ; Altube, L. ; Álvarez Navascués, F. ; Anibarro, L. ; Barrón, M. ; Bermúdez, P. ; Blanquer, R. ; Borderías, L. ; Bustamante, A. ; Calpe, J. L. ; Caminero, J. A. ; Cañas, F. ; Casas, F. ; Casas, X. ; Cases, E. ; Castrodeza, R. ; Cebrián, J. J. ; Ciruelos, J. E. ; Delgado, A. E. ; de Souza, M. L. ; Díaz, D. ; Fernández, B. ; Fernández, A. ; Gallardo, J. ; Gallego, M. ; GarcíaClemente, M. M. ; García, C. ; García, F. J. ; Garros, F. J. ; Gullón, J. A. ; Hidalgo, C. ; Iglesias, M. ; Jiménez, G. ; Jiménez, M. A. ; Kindelan, J. M. ; Laparra, J. ; Lera, R. ; Lloret, T. ; Marín, M. ; Martínez, J. T. ; Martínez, E. ; Martínez, A. ; Medina, J. F. ; Melero, C. ; Milà, C. ; Mir, I. ; Morales, C. ; Morales, M. A. ; Moreno, V. ; Muñoz, A. ; Muñoz, L. ; Muñoz, C. ; Muñoz, J. A. ; Parra, I. ; Penas, A. ; Pérez, J. A. ; Rivas, P. ; Rodríguez, J. ; Ruiz-Manzano, J. ; Sala, J. ; Sánchez, M. ; Sánchez, P. ; Sanz, F. ; Somoza, M. ; Trujillo, E. ; Valencia, E. ; Vargas, A. ; Vidal, I. ; Vidal, R. ; Villanueva, M. A. ; Villar, A. ; Vizcaya, M. ; Zabaleta, M. ; Zubillaga, G. / Cumplimiento en España de la norma de prescribir cuatro fármacos en la fase intensiva del tratamiento estándar de la tuberculosis. In: Archivos de Bronconeumologia. 2016 ; Vol. 52, No. 5. pp. 262-268.
@article{5487bbbcaf3643d8a4fd956737093a97,
title = "Cumplimiento en Espa{\~n}a de la norma de prescribir cuatro f{\'a}rmacos en la fase intensiva del tratamiento est{\'a}ndar de la tuberculosis",
abstract = "Introduction: International and Spanish guidelines recommend a 4-drug regimen in the intensive treatment of tuberculosis (TB). The aim of our study was to determine if these recommendations are followed in Spain, and the factors associated with the use of 3 drugs (standard regimen without ethambutol). Methodology: Observational, multicenter, retrospective analysis of data from patients diagnosed with TB in practically all Spanish Autonomous Communities between 2007 and 2102. Factors associated with the use of 3 drugs were analyzed using logistic regression, and odds ratios (OR) and corresponding 95{\%} confidence intervals (CI) were calculated. Results: A total of 3,189 patients were included, 1,413 (44.3{\%}) of whom received 3 drugs. The percentage of 3-drug users among patients with positive sputum smear was 41.2{\%}; among patients with resistance to at least 1 drug, 36.1{\%}; among HIV-infected patients, 31.4{\%}; and among immigrants, 24.8{\%}. Factors associated with the use of 3 drugs were: female sex (OR = 1.18; CI: 1.00-1.39); native Spanish (OR = 3.09; CI: 2.58-3.70); retired (OR = 1.42; CI: 1.14-1.77); homeless (OR = 3.10; CI: 1.52-6.43); living alone (OR = 1.62; CI: 1.11-2.36); living in a family (OR = 1.97; CI: 1.48-2.65); seen by specialists in the region (OR = 1.37; CI: 1.10;1.70); no HIV infection (OR = 1.63; CI: 1.09-2.48); and negative sputum smear with positive culture (OR = 1.59; CI: 1.25-2.02). Conclusions: A large proportion of TB patients receive intensive treatment with 3 drugs. TB treatment recommendations should be followed, both in routine clinical practice and by the National Plan for Prevention and Control of Tuberculosis in Spain.",
keywords = "Adherence, Guidelines, Treatment, Tuberculosis",
author = "Garc{\'i}a-Garc{\'i}a, {Jos{\'e} Mar{\'i}a} and Teresa Rodrigo and Mart{\'i} Casals and Juan Ruiz-Manzano and Teresa Pascual-Pascual and Cayl{\`a}, {Joan A.} and R. Ag{\"u}ero and Alc{\'a}zar, {J. L.} and N. Altet and L. Altube and {{\'A}lvarez Navascu{\'e}s}, F. and L. Anibarro and M. Barr{\'o}n and P. Berm{\'u}dez and R. Blanquer and L. Border{\'i}as and A. Bustamante and Calpe, {J. L.} and Caminero, {J. A.} and F. Ca{\~n}as and F. Casas and X. Casas and E. Cases and R. Castrodeza and Cebri{\'a}n, {J. J.} and Ciruelos, {J. E.} and Delgado, {A. E.} and {de Souza}, {M. L.} and D. D{\'i}az and B. Fern{\'a}ndez and A. Fern{\'a}ndez and J. Gallardo and M. Gallego and Garc{\'i}aClemente, {M. M.} and C. Garc{\'i}a and Garc{\'i}a, {F. J.} and Garros, {F. J.} and Gull{\'o}n, {J. A.} and C. Hidalgo and M. Iglesias and G. Jim{\'e}nez and Jim{\'e}nez, {M. A.} and Kindelan, {J. M.} and J. Laparra and R. Lera and T. Lloret and M. Mar{\'i}n and Mart{\'i}nez, {J. T.} and E. Mart{\'i}nez and A. Mart{\'i}nez and Medina, {J. F.} and C. Melero and C. Mil{\`a} and I. Mir and C. Morales and Morales, {M. A.} and V. Moreno and A. Mu{\~n}oz and L. Mu{\~n}oz and C. Mu{\~n}oz and Mu{\~n}oz, {J. A.} and I. Parra and A. Penas and P{\'e}rez, {J. A.} and P. Rivas and J. Rodr{\'i}guez and J. Ruiz-Manzano and J. Sala and M. S{\'a}nchez and P. S{\'a}nchez and F. Sanz and M. Somoza and E. Trujillo and E. Valencia and A. Vargas and I. Vidal and R. Vidal and Villanueva, {M. A.} and A. Villar and M. Vizcaya and M. Zabaleta and G. Zubillaga",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.arbres.2015.11.007",
language = "Spanish",
volume = "52",
pages = "262--268",
journal = "Archivos de Bronconeumologia",
issn = "0300-2896",
publisher = "Ediciones Doyma, S.L.",
number = "5",

}

TY - JOUR

T1 - Cumplimiento en España de la norma de prescribir cuatro fármacos en la fase intensiva del tratamiento estándar de la tuberculosis

AU - García-García, José María

AU - Rodrigo, Teresa

AU - Casals, Martí

AU - Ruiz-Manzano, Juan

AU - Pascual-Pascual, Teresa

AU - Caylà, Joan A.

AU - Agüero, R.

AU - Alcázar, J. L.

AU - Altet, N.

AU - Altube, L.

AU - Álvarez Navascués, F.

AU - Anibarro, L.

AU - Barrón, M.

AU - Bermúdez, P.

AU - Blanquer, R.

AU - Borderías, L.

AU - Bustamante, A.

AU - Calpe, J. L.

AU - Caminero, J. A.

AU - Cañas, F.

AU - Casas, F.

AU - Casas, X.

AU - Cases, E.

AU - Castrodeza, R.

AU - Cebrián, J. J.

AU - Ciruelos, J. E.

AU - Delgado, A. E.

AU - de Souza, M. L.

AU - Díaz, D.

AU - Fernández, B.

AU - Fernández, A.

AU - Gallardo, J.

AU - Gallego, M.

AU - GarcíaClemente, M. M.

AU - García, C.

AU - García, F. J.

AU - Garros, F. J.

AU - Gullón, J. A.

AU - Hidalgo, C.

AU - Iglesias, M.

AU - Jiménez, G.

AU - Jiménez, M. A.

AU - Kindelan, J. M.

AU - Laparra, J.

AU - Lera, R.

AU - Lloret, T.

AU - Marín, M.

AU - Martínez, J. T.

AU - Martínez, E.

AU - Martínez, A.

AU - Medina, J. F.

AU - Melero, C.

AU - Milà, C.

AU - Mir, I.

AU - Morales, C.

AU - Morales, M. A.

AU - Moreno, V.

AU - Muñoz, A.

AU - Muñoz, L.

AU - Muñoz, C.

AU - Muñoz, J. A.

AU - Parra, I.

AU - Penas, A.

AU - Pérez, J. A.

AU - Rivas, P.

AU - Rodríguez, J.

AU - Ruiz-Manzano, J.

AU - Sala, J.

AU - Sánchez, M.

AU - Sánchez, P.

AU - Sanz, F.

AU - Somoza, M.

AU - Trujillo, E.

AU - Valencia, E.

AU - Vargas, A.

AU - Vidal, I.

AU - Vidal, R.

AU - Villanueva, M. A.

AU - Villar, A.

AU - Vizcaya, M.

AU - Zabaleta, M.

AU - Zubillaga, G.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Introduction: International and Spanish guidelines recommend a 4-drug regimen in the intensive treatment of tuberculosis (TB). The aim of our study was to determine if these recommendations are followed in Spain, and the factors associated with the use of 3 drugs (standard regimen without ethambutol). Methodology: Observational, multicenter, retrospective analysis of data from patients diagnosed with TB in practically all Spanish Autonomous Communities between 2007 and 2102. Factors associated with the use of 3 drugs were analyzed using logistic regression, and odds ratios (OR) and corresponding 95% confidence intervals (CI) were calculated. Results: A total of 3,189 patients were included, 1,413 (44.3%) of whom received 3 drugs. The percentage of 3-drug users among patients with positive sputum smear was 41.2%; among patients with resistance to at least 1 drug, 36.1%; among HIV-infected patients, 31.4%; and among immigrants, 24.8%. Factors associated with the use of 3 drugs were: female sex (OR = 1.18; CI: 1.00-1.39); native Spanish (OR = 3.09; CI: 2.58-3.70); retired (OR = 1.42; CI: 1.14-1.77); homeless (OR = 3.10; CI: 1.52-6.43); living alone (OR = 1.62; CI: 1.11-2.36); living in a family (OR = 1.97; CI: 1.48-2.65); seen by specialists in the region (OR = 1.37; CI: 1.10;1.70); no HIV infection (OR = 1.63; CI: 1.09-2.48); and negative sputum smear with positive culture (OR = 1.59; CI: 1.25-2.02). Conclusions: A large proportion of TB patients receive intensive treatment with 3 drugs. TB treatment recommendations should be followed, both in routine clinical practice and by the National Plan for Prevention and Control of Tuberculosis in Spain.

AB - Introduction: International and Spanish guidelines recommend a 4-drug regimen in the intensive treatment of tuberculosis (TB). The aim of our study was to determine if these recommendations are followed in Spain, and the factors associated with the use of 3 drugs (standard regimen without ethambutol). Methodology: Observational, multicenter, retrospective analysis of data from patients diagnosed with TB in practically all Spanish Autonomous Communities between 2007 and 2102. Factors associated with the use of 3 drugs were analyzed using logistic regression, and odds ratios (OR) and corresponding 95% confidence intervals (CI) were calculated. Results: A total of 3,189 patients were included, 1,413 (44.3%) of whom received 3 drugs. The percentage of 3-drug users among patients with positive sputum smear was 41.2%; among patients with resistance to at least 1 drug, 36.1%; among HIV-infected patients, 31.4%; and among immigrants, 24.8%. Factors associated with the use of 3 drugs were: female sex (OR = 1.18; CI: 1.00-1.39); native Spanish (OR = 3.09; CI: 2.58-3.70); retired (OR = 1.42; CI: 1.14-1.77); homeless (OR = 3.10; CI: 1.52-6.43); living alone (OR = 1.62; CI: 1.11-2.36); living in a family (OR = 1.97; CI: 1.48-2.65); seen by specialists in the region (OR = 1.37; CI: 1.10;1.70); no HIV infection (OR = 1.63; CI: 1.09-2.48); and negative sputum smear with positive culture (OR = 1.59; CI: 1.25-2.02). Conclusions: A large proportion of TB patients receive intensive treatment with 3 drugs. TB treatment recommendations should be followed, both in routine clinical practice and by the National Plan for Prevention and Control of Tuberculosis in Spain.

KW - Adherence

KW - Guidelines

KW - Treatment

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84962091937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962091937&partnerID=8YFLogxK

U2 - 10.1016/j.arbres.2015.11.007

DO - 10.1016/j.arbres.2015.11.007

M3 - Article

VL - 52

SP - 262

EP - 268

JO - Archivos de Bronconeumologia

JF - Archivos de Bronconeumologia

SN - 0300-2896

IS - 5

ER -